# ELOXATIN
> **NDA021492** · New Drug Application · Sponsor: SANOFI AVENTIS US · Approved 2002-08-09
## Drug
- **FDA Application Number:** NDA021492
- **Application type:** New Drug Application
- **Brand name:** ELOXATIN
- **Generic name:** Oxaliplatin
- **Active ingredients:** OXALIPLATIN
- **Dosage form:** INJECTABLE
- **Route:** INTRAVENOUS
- **Marketing status:** Discontinued
- **Sponsor:** SANOFI AVENTIS US
- **First approval:** 2002-08-09
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=021492)
---
*MORVS · CC0 1.0*